SCHEMBL24577394

SCHEMBL24577394

CC1CN(CC(=O)NC2=CNC(C)C(NC(=O)c3cnn4cc(Br)sc34)=C2)C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.33
▸ MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24579106 0.91 RAB9A (0.34) POLB
SCHEMBL24578957 0.90 RAB9A (0.34) POLB
SCHEMBL24577267 0.90 WNT1 (0.33) POLB
SCHEMBL24577359 0.89 POLB (0.38) POLBMAPK8
SCHEMBL24577373 0.88 GSK3B (0.39) POLBMAPK8
SCHEMBL24577557 0.88 — —
SCHEMBL24578968 0.87 GSK3B (0.35) —
SCHEMBL24577380 0.87 — —
SCHEMBL24577048 0.87 WNT1 (0.31) —
SCHEMBL24579061 0.87 POLB (0.30) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback